Connection

Syed Hasan to Humans

Back to Details
This is a "connection" page, showing publications Syed Hasan has written about Humans.
Syed Hasan
Connection Strength
0.616
Humans
  1. Amiodarone in COVID-19: let's not forget its potential for pulmonary toxicity. Eur J Prev Cardiol. 2022 02 09; 28(18):e52.
    View in: PubMed
    Score: 0.008
  2. Corticosteroid-related In-Hospital Hyperglycemia: Does It Negate Mortality Benefits in Coronavirus Disease 2019? Clin Infect Dis. 2021 11 02; 73(9):e2848-e2849.
    View in: PubMed
    Score: 0.008
  3. An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan. Vaccine. 2021 08 31; 39(37):5251-5253.
    View in: PubMed
    Score: 0.008
  4. The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review. Expert Rev Anti Infect Ther. 2022 02; 20(2):211-229.
    View in: PubMed
    Score: 0.008
  5. Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies. Inflammopharmacology. 2021 Aug; 29(4):1075-1090.
    View in: PubMed
    Score: 0.008
  6. Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials. Expert Rev Respir Med. 2021 08; 15(8):1049-1055.
    View in: PubMed
    Score: 0.008
  7. Do the Meta-Analyses Provide a Clean Bill of Health to the Use of Renin-angiotensin System Inhibitors in Coronavirus Disease 2019 (COVID-19)? Clin Infect Dis. 2021 07 01; 73(1):164-165.
    View in: PubMed
    Score: 0.008
  8. Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Hypertens Res. 2021 08; 44(8):1042-1045.
    View in: PubMed
    Score: 0.008
  9. Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK. J Infect. 2021 07; 83(1):e14-e15.
    View in: PubMed
    Score: 0.008
  10. Cerebral Venous Thrombosis following COVID-19 Vaccination. J Stroke Cerebrovasc Dis. 2021 10; 30(10):105866.
    View in: PubMed
    Score: 0.008
  11. Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury. Int Braz J Urol. 2021 May-Jun; 47(3):690-691.
    View in: PubMed
    Score: 0.008
  12. Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One. Chest. 2021 05; 159(5):2108-2109.
    View in: PubMed
    Score: 0.008
  13. The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammopharmacology. 2021 Jun; 29(3):641-644.
    View in: PubMed
    Score: 0.008
  14. Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis. J Thromb Thrombolysis. 2021 Jul; 52(1):124-129.
    View in: PubMed
    Score: 0.008
  15. The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis. Pharmacol Rep. 2021 Oct; 73(5):1473-1479.
    View in: PubMed
    Score: 0.007
  16. Do sleep quality and sleep duration before or after COVID-19 vaccination affect antibody response? Chronobiol Int. 2021 07; 38(7):941-943.
    View in: PubMed
    Score: 0.007
  17. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19. Daru. 2021 Jun; 29(1):217-221.
    View in: PubMed
    Score: 0.007
  18. Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis. Mayo Clin Proc. 2021 05; 96(5):1365-1367.
    View in: PubMed
    Score: 0.007
  19. Effect of COVID-19 on viral hepatitis services in Pakistan. Lancet Gastroenterol Hepatol. 2021 03; 6(3):163-164.
    View in: PubMed
    Score: 0.007
  20. COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK. Expert Rev Respir Med. 2021 08; 15(8):973-978.
    View in: PubMed
    Score: 0.007
  21. Insulin Treatment May Not Be Associated with Increased Mortality in Patients with COVID-19 and Concurrent Diabetes. Endocr Res. 2021 Feb-May; 46(2):51-52.
    View in: PubMed
    Score: 0.007
  22. Potential interactions between COVID-19 vaccines and antiepileptic drugs. Seizure. 2021 03; 86:80-81.
    View in: PubMed
    Score: 0.007
  23. The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2021 Aug; 77(8):1089-1094.
    View in: PubMed
    Score: 0.007
  24. Interferon-based therapies in COVID-19. Int Immunopharmacol. 2021 Apr; 93:107415.
    View in: PubMed
    Score: 0.007
  25. Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19. Rheumatol Int. 2021 03; 41(3):677-678.
    View in: PubMed
    Score: 0.007
  26. Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic. Obes Surg. 2021 01; 31(1):413-414.
    View in: PubMed
    Score: 0.007
  27. Pharmacologic therapeutic options for thromboprophylaxis in COVID-19. J Thromb Thrombolysis. 2021 Jan; 51(1):29-30.
    View in: PubMed
    Score: 0.007
  28. Persistent fatigue in patients with COVID-19. Clin Med (Lond). 2021 01; 21(1):e117.
    View in: PubMed
    Score: 0.007
  29. A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19. Therapie. 2021 Jul-Aug; 76(4):361-364.
    View in: PubMed
    Score: 0.007
  30. The use of combined hormonal contraceptives amid the COVID-19 pandemic. Eur J Contracept Reprod Health Care. 2021 02; 26(1):85-86.
    View in: PubMed
    Score: 0.007
  31. Use of Pharmacologic Agents With Weight Gain Potential for Panic Disorder Amid the COVID-19 Pandemic. Prim Care Companion CNS Disord. 2020 11 25; 22(6).
    View in: PubMed
    Score: 0.007
  32. Dexamethasone or hydrocortisone in COVID-19? Cleve Clin J Med. 2020 11 23; 87(12):715.
    View in: PubMed
    Score: 0.007
  33. Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic. Expert Rev Cardiovasc Ther. 2021 01; 19(1):99-100.
    View in: PubMed
    Score: 0.007
  34. Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials. J Med Virol. 2021 04; 93(4):1860-1861.
    View in: PubMed
    Score: 0.007
  35. Prochlorperazine for nausea and vomiting accompanied COVID-19. J Gastroenterol Hepatol. 2021 Feb; 36(2):524-525.
    View in: PubMed
    Score: 0.007
  36. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. J Thromb Thrombolysis. 2020 Nov; 50(4):814-821.
    View in: PubMed
    Score: 0.007
  37. Concurrent Antibiotic Therapy in Disseminated Strongyloidiasis. Am J Trop Med Hyg. 2020 11; 103(5):2149.
    View in: PubMed
    Score: 0.007
  38. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021 Feb; 22(2):229-240.
    View in: PubMed
    Score: 0.007
  39. Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis. J Intern Med. 2021 01; 289(1):125-128.
    View in: PubMed
    Score: 0.007
  40. Macrolides for patients with COVID-19 and concurrent pertussis infection. Diagn Microbiol Infect Dis. 2021 Feb; 99(2):115245.
    View in: PubMed
    Score: 0.007
  41. Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease. Rheumatol Int. 2020 12; 40(12):2117-2118.
    View in: PubMed
    Score: 0.007
  42. Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19. Eur J Clin Pharmacol. 2021 Mar; 77(3):435-437.
    View in: PubMed
    Score: 0.007
  43. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? Allergy. 2021 03; 76(3):959-960.
    View in: PubMed
    Score: 0.007
  44. The Use of Pharmacological Preventive Therapy for Migraine With Weight Gain Potential Amid Coronavirus Disease 2019 Pandemic. Headache. 2020 10; 60(9):2085-2086.
    View in: PubMed
    Score: 0.007
  45. Use of Azithromycin in COVID-19: A Cautionary Tale. Clin Drug Investig. 2020 10; 40(10):989-990.
    View in: PubMed
    Score: 0.007
  46. Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis. J Med Virol. 2021 02; 93(2):695-697.
    View in: PubMed
    Score: 0.007
  47. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020 11; 14(11):1149-1163.
    View in: PubMed
    Score: 0.007
  48. Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials? Int J Infect Dis. 2020 Dec; 101:107-120.
    View in: PubMed
    Score: 0.007
  49. Azithromycin in patients with COVID-19: Friend or foe? Clin Microbiol Infect. 2021 01; 27(1):136-137.
    View in: PubMed
    Score: 0.007
  50. The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19. Obesity (Silver Spring). 2020 11; 28(11):2035.
    View in: PubMed
    Score: 0.007
  51. Revascularization in COVID-19 patients with renal infarction. Am J Transplant. 2021 03; 21(3):1345.
    View in: PubMed
    Score: 0.007
  52. The use of antimotility drugs in COVID-19 associated diarrhea. J Infect. 2021 02; 82(2):e19.
    View in: PubMed
    Score: 0.007
  53. Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19. Rev Esp Cardiol (Engl Ed). 2021 02; 74(2):200-201.
    View in: PubMed
    Score: 0.007
  54. Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2020 Dec; 20(6):571-590.
    View in: PubMed
    Score: 0.007
  55. The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19. Rev Esp Cardiol (Engl Ed). 2021 01; 74(1):114-115.
    View in: PubMed
    Score: 0.007
  56. Meta-analysis of Effect of Statins in Patients with COVID-19. Am J Cardiol. 2020 11 01; 134:153-155.
    View in: PubMed
    Score: 0.007
  57. Montelukast in children with allergic rhinitis amid COVID-19 pandemic. Acta Paediatr. 2020 10; 109(10):2151.
    View in: PubMed
    Score: 0.007
  58. Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic. J Formos Med Assoc. 2021 01; 120(1 Pt 3):772-773.
    View in: PubMed
    Score: 0.007
  59. Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. J Stroke Cerebrovasc Dis. 2020 12; 29(12):105222.
    View in: PubMed
    Score: 0.007
  60. Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide. Am J Cardiovasc Drugs. 2020 Aug; 20(4):301-309.
    View in: PubMed
    Score: 0.007
  61. Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients. Eur J Hosp Pharm. 2021 01; 28(1):42-46.
    View in: PubMed
    Score: 0.007
  62. Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients. Expert Rev Cardiovasc Ther. 2020 Aug; 18(8):475-485.
    View in: PubMed
    Score: 0.007
  63. Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey. Res Social Adm Pharm. 2021 01; 17(1):1832-1837.
    View in: PubMed
    Score: 0.007
  64. Role of frailty in COVID-19 patients. Intensive Care Med. 2020 10; 46(10):1956-1957.
    View in: PubMed
    Score: 0.007
  65. Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury. J Am Soc Nephrol. 2020 08; 31(8):1917-1918.
    View in: PubMed
    Score: 0.007
  66. Could melatonin be used in COVID-19 patients with laryngopharyngeal reflux disease? J Med Virol. 2021 01; 93(1):92-93.
    View in: PubMed
    Score: 0.007
  67. Use of low-molecular-weight heparin in COVID-19 patients. J Vasc Surg Venous Lymphat Disord. 2020 09; 8(5):900-901.
    View in: PubMed
    Score: 0.007
  68. Metformin use amid coronavirus disease 2019 pandemic. J Med Virol. 2020 11; 92(11):2401-2402.
    View in: PubMed
    Score: 0.007
  69. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. Am J Cardiovasc Drugs. 2020 Jun; 20(3):217-221.
    View in: PubMed
    Score: 0.007
  70. Vitamin D Supplementation in Influenza and COVID-19 Infections Comment on: "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths" Nutrients 2020, 12(4), 988. Nutrients. 2020 Jun 01; 12(6).
    View in: PubMed
    Score: 0.007
  71. Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respir Med. 2020 Aug - Sep; 170:106045.
    View in: PubMed
    Score: 0.007
  72. Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis. Infection. 2020 10; 48(5):805-806.
    View in: PubMed
    Score: 0.007
  73. Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures? Res Social Adm Pharm. 2021 02; 17(2):456-459.
    View in: PubMed
    Score: 0.007
  74. Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea. Value Health Reg Issues. 2019 May; 18:18-23.
    View in: PubMed
    Score: 0.006
  75. Association between beliefs about medicines and self-medication with analgesics among patients with dental pain. PLoS One. 2018; 13(8):e0201776.
    View in: PubMed
    Score: 0.006
  76. Academic dishonesty among academics in Malaysia: a comparison between healthcare and non-healthcare academics. BMC Med Educ. 2018 Jul 17; 18(1):168.
    View in: PubMed
    Score: 0.006
  77. Economic evaluation of prescribing conventional and newer oral anticoagulants in older adults. Expert Rev Pharmacoecon Outcomes Res. 2018 08; 18(4):371-377.
    View in: PubMed
    Score: 0.006
  78. Consolidated Medication Review Algorithm to Improve Medications Use in Older Adults: Components, Scoring Scheme, and Implementation. J Am Med Dir Assoc. 2018 08; 19(8):717-718.
    View in: PubMed
    Score: 0.006
  79. An Evaluation of the Central Nervous System Medication Use and Frailty among Residents of Aged Care Homes in Malaysia. Neuroepidemiology. 2017; 49(1-2):82-90.
    View in: PubMed
    Score: 0.006
  80. Economic evaluation of pharmacist-led medication reviews in residential aged care facilities. Expert Rev Pharmacoecon Outcomes Res. 2017 Oct; 17(5):431-439.
    View in: PubMed
    Score: 0.006
  81. An evaluation of medication appropriateness and frailty among residents of aged care homes in Malaysia: A cross-sectional study. Medicine (Baltimore). 2017 Sep; 96(35):e7929.
    View in: PubMed
    Score: 0.006
  82. Publish or Perish: A Mandate With Negative Collateral Consequences. Acad Med. 2017 02; 92(2):140.
    View in: PubMed
    Score: 0.006
  83. Implementing professionalism by deprofessionalized strategies: A moral quandary. Curr Pharm Teach Learn. 2017 Jan - Feb; 9(1):9-11.
    View in: PubMed
    Score: 0.006
  84. Innovating medication reviews through a technology-enabled process. Res Social Adm Pharm. 2022 04; 18(4):2700-2705.
    View in: PubMed
    Score: 0.002
  85. Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS-CoV-2 in the respiratory tract. Pharmacol Res Perspect. 2021 02; 9(1):e00698.
    View in: PubMed
    Score: 0.002
  86. Association of frailty and mortality in patients with COVID-19: a meta-analysis. Br J Anaesth. 2021 03; 126(3):e108-e110.
    View in: PubMed
    Score: 0.002
  87. Surveillance study of asymptomatic and presymptomatic coronavirus disease 2019 (COVID-19) in care homes in Northern Ireland. Infect Control Hosp Epidemiol. 2021 11; 42(11):1400-1402.
    View in: PubMed
    Score: 0.002
  88. Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety. J Drug Target. 2020 Aug-Sep; 28(7-8):683-699.
    View in: PubMed
    Score: 0.002
  89. Pharmacy, pharmaceuticals and public policy: Solving the puzzle. Res Social Adm Pharm. 2020 Jun; 16(6):840-843.
    View in: PubMed
    Score: 0.002
  90. Interventions to improve insulin prescribing practice for people with diabetes in hospital: a systematic review. Diabet Med. 2019 08; 36(8):948-960.
    View in: PubMed
    Score: 0.002
  91. Rising Events and Improved Outcomes of Gastrointestinal Bleed With Shock in USA: A 12-year National Analysis. J Clin Gastroenterol. 2019 May/Jun; 53(5):e194-e201.
    View in: PubMed
    Score: 0.002
  92. Extensively drug-resistant typhoid fever in Pakistan. Lancet Infect Dis. 2019 03; 19(3):242-243.
    View in: PubMed
    Score: 0.002
  93. Cost analysis of type 2 diabetes mellitus treatment in economically developed countries. Expert Rev Pharmacoecon Outcomes Res. 2019 02; 19(1):5-14.
    View in: PubMed
    Score: 0.002
  94. Patient access to medicines in two countries with similar health systems and differing medicines policies: Implications from a comprehensive literature review. Res Social Adm Pharm. 2019 03; 15(3):231-243.
    View in: PubMed
    Score: 0.002
  95. Patients' Perceptions of Dental Students' Empathic, Person-Centered Care in a Dental School Clinic in Malaysia. J Dent Educ. 2017 Apr; 81(4):404-412.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.